ICU
SeaStar Medical Holding Corporation
Price Chart
Latest Quote
$3.09
-0.38 (-10.95%)
Current Price
| Previous Close | $3.47 |
| Open | $3.42 |
| Day High | $3.42 |
| Day Low | $3.08 |
| Volume | 158,963 |
Stock Information
| Shares Outstanding | 4.00M |
| Total Debt | $331K |
| Cash Equivalents | $9.35M |
| Revenue | $1.44M |
| Net Income | $-11.90M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $12.35M |
| EPS (TTM) | $-2.38 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $3.33M |
| Sales | $1.44M |
| Income | $-11.90M |
| Book/sh | $1.83 |
| Cash/sh | $2.34 |
| Employees | 17 |
Financial Ratios
| Quick Ratio | 2.41 |
| Current Ratio | 2.73 |
| Debt/Eq | 4.53 |
Returns & Margins
| ROA | -79.24% |
| ROE | -302.00% |
| Gross Margin | 93.11% |
| Operating Margin | -727.88% |
Ownership
| Insider Ownership | 11.96% |
| Institutional Ownership | 7.66% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -1.20 |
| P/S | 8.60 |
| P/B | 1.69 |
Analyst Data
| Recommendation | none |
| Target Price | $10.00 |
Technical Indicators
| SMA20 | $3.18 |
| SMA50 | $3.80 |
| SMA200 | $4.02 |
| RSI | 45.37 |
| ATR | 0.3051 |
| Shares Float | 3.96M |
| Short Float | 3.56% |
| Short Ratio | 1.82 |
| Volatility | -1.03 |
| Rel Volume | 1.79 |
Performance History
| Week | +1.64% |
| Month | -17.60% |
| Quarter | +37.95% |
| 6 Months | +26.12% |
| YTD | +17.49% |
| Year | -6.93% |
| 3 Years | -97.71% |
| 5 Years | -99.88% |
| 10 Years | -99.87% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-24 | $3.09 | 160,900 |
| 2026-06-23 | $3.47 | 98,000 |
| 2026-06-22 | $3.24 | 59,600 |
| 2026-06-18 | $3.12 | 42,400 |
| 2026-06-17 | $3.06 | 51,000 |
| 2026-06-16 | $3.04 | 42,600 |
| 2026-06-15 | $3.13 | 109,700 |
| 2026-06-12 | $2.98 | 168,900 |
| 2026-06-11 | $2.73 | 107,400 |
| 2026-06-10 | $2.63 | 87,800 |
| 2026-06-09 | $2.78 | 106,100 |
| 2026-06-08 | $2.90 | 94,000 |
| 2026-06-05 | $2.94 | 103,600 |
| 2026-06-04 | $3.13 | 121,800 |
| 2026-06-03 | $3.28 | 101,600 |
| 2026-06-02 | $3.53 | 62,200 |
| 2026-06-01 | $3.64 | 74,000 |
| 2026-05-29 | $3.71 | 78,800 |
| 2026-05-28 | $3.66 | 74,800 |
| 2026-05-27 | $3.59 | 56,600 |
| 2026-05-26 | $3.58 | 110,100 |
About SeaStar Medical Holding Corporation
SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.
đ° Latest News
SeaStar Medical Holding Corporation Q2 2026 Earnings Call Summary
Moby âĸ 2026-05-14T12:30:00Z
SeaStar Medical Holding Corp (ICU) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ...
GuruFocus.com âĸ 2026-05-14T05:01:51ZSeaStar Medical (ICU) Q1 2026 Earnings Transcript
Motley Fool âĸ 2026-05-13T21:48:05Z
Full Transcript: SeaStar Medical Holding Q1 2026 Earnings Call
Benzinga âĸ 2026-05-13T21:20:42Z
SeaStar Medical Holding Corp (ICU) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...
GuruFocus.com âĸ 2026-03-26T03:01:50ZSeaStar Medical Holding Corp (ICU) Q3 2025 Earnings Call Highlights: Revenue Surge and ...
GuruFocus.com âĸ 2025-11-14T05:04:37ZSeaStar Medical (ICU) Q3 2025 Earnings Transcript
Motley Fool âĸ 2025-11-13T22:45:28Z
SeaStar Medical Holding Corp (ICU) Q2 2025 Earnings Call Highlights: Record Revenue Growth and ...
GuruFocus.com âĸ 2025-08-14T07:14:09ZTop Midday Gainers
MT Newswires âĸ 2025-06-25T18:23:35Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $53,000 | $0 | $0 | - |
| Cost Of Revenue | $53,000 | $0 | $0 | - |
| Total Revenue | $1,234,000 | $135,000 | $0 | $0 |
| Operating Revenue | $1,234,000 | $135,000 | $0 | $0 |
| Expenses | ||||
| Interest Expense | $31,000 | $244,000 | $1,081,000 | $630,000 |
| Total Expenses | $13,409,000 | $17,977,000 | $14,210,000 | $11,609,000 |
| Other Income Expense | $32,000 | $-6,842,000 | $-10,941,000 | $50,000 |
| Net Non Operating Interest Income Expense | $-4,000 | $-143,000 | $-1,081,000 | $-630,000 |
| Total Other Finance Cost | $298,000 | - | - | - |
| Interest Expense Non Operating | $31,000 | $244,000 | $1,081,000 | $630,000 |
| Operating Expense | $13,356,000 | $17,977,000 | $14,210,000 | $11,609,000 |
| General And Administrative Expense | $5,838,000 | $8,872,000 | $8,237,000 | $6,916,000 |
| Other Non Operating Income Expenses | - | $-6,145,000 | $-5,229,000 | - |
| Other Operating Expenses | - | - | - | $2,190,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-12,150,000 | $-24,830,000 | $-26,232,000 | $-12,190,000 |
| Net Interest Income | $-4,000 | $-143,000 | $-1,081,000 | $-630,000 |
| Interest Income | $325,000 | $101,000 | $0 | - |
| Normalized Income | $-12,175,280 | $-24,133,000 | $-20,520,000 | $-12,240,000 |
| Net Income From Continuing And Discontinued Operation | $-12,150,000 | $-24,830,000 | $-26,232,000 | $-12,190,000 |
| Total Operating Income As Reported | $-12,175,000 | $-17,842,000 | $-14,210,000 | $-11,609,000 |
| Net Income Common Stockholders | $-12,150,000 | $-24,830,000 | $-26,232,000 | $-12,190,000 |
| Net Income | $-12,150,000 | $-24,830,000 | $-26,232,000 | $-12,190,000 |
| Net Income Including Noncontrolling Interests | $-12,150,000 | $-24,830,000 | $-26,232,000 | $-12,190,000 |
| Net Income Continuous Operations | $-12,150,000 | $-24,830,000 | $-26,232,000 | $-12,190,000 |
| Pretax Income | $-12,147,000 | $-24,827,000 | $-26,232,000 | $-12,189,000 |
| Interest Income Non Operating | $325,000 | $101,000 | $0 | - |
| Operating Income | $-12,175,000 | $-17,842,000 | $-14,210,000 | $-11,609,000 |
| Gross Profit | $1,181,000 | $135,000 | $0 | - |
| Special Income Charges | - | $0 | $-4,949,000 | $0 |
| Per Share | ||||
| Diluted EPS | $-5.86 | $-66.30 | $-302.60 | $-700.00 |
| Basic EPS | $-5.86 | $-66.30 | $-302.60 | $-700.00 |
| Other | ||||
| Tax Effect Of Unusual Items | $6,720 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-12,148,000 | $-23,886,000 | $-19,439,000 | $-11,609,000 |
| Total Unusual Items | $32,000 | $-697,000 | $-5,712,000 | $50,000 |
| Total Unusual Items Excluding Goodwill | $32,000 | $-697,000 | $-5,712,000 | $50,000 |
| EBITDA (Bullshit earnings) | $-12,116,000 | $-24,583,000 | $-25,151,000 | $-11,559,000 |
| EBIT | $-12,116,000 | $-24,583,000 | $-25,151,000 | $-11,559,000 |
| Diluted Average Shares | $2,073,087 | $374,355 | $86,681 | $32,845 |
| Basic Average Shares | $2,073,087 | $374,355 | $86,681 | $32,845 |
| Diluted NI Availto Com Stockholders | $-12,150,000 | $-24,830,000 | $-26,232,000 | $-12,190,000 |
| Tax Provision | $3,000 | $3,000 | $0 | $1,000 |
| Gain On Sale Of Security | $32,000 | $-697,000 | $-763,000 | $50,000 |
| Research And Development | $7,518,000 | $9,105,000 | $5,973,000 | $2,503,000 |
| Selling General And Administration | $5,838,000 | $8,872,000 | $8,237,000 | $6,916,000 |
| Other Gand A | $5,838,000 | $8,872,000 | $8,237,000 | $6,916,000 |
| Other Special Charges | - | - | $4,949,000 | - |
| Gain On Sale Of Ppe | - | - | - | - |
Fetched: 2026-06-24
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $10,416,000 | $-2,183,000 | $-13,870,000 | $-20,762,000 |
| Total Assets | $14,158,000 | $4,658,000 | $3,513,000 | $3,038,000 |
| Total Non Current Assets | $578,000 | $892,000 | $1,205,000 | $1,519,000 |
| Other Non Current Assets | $578,000 | $892,000 | $1,205,000 | $1,519,000 |
| Current Assets | $13,580,000 | $3,766,000 | $2,308,000 | $1,519,000 |
| Prepaid Assets | $1,297,000 | $1,835,000 | $2,132,000 | $1,460,000 |
| Inventory | $66,000 | $0 | - | - |
| Receivables | $237,000 | $112,000 | $0 | $12,000 |
| Accounts Receivable | $237,000 | $112,000 | $0 | - |
| Allowance For Doubtful Accounts Receivable | $-3,000 | $0 | - | - |
| Gross Accounts Receivable | $240,000 | $112,000 | - | - |
| Cash Cash Equivalents And Short Term Investments | $11,980,000 | $1,819,000 | $176,000 | $47,000 |
| Cash And Cash Equivalents | $11,980,000 | $1,819,000 | $176,000 | $47,000 |
| Cash Financial | $11,980,000 | $1,819,000 | $176,000 | $47,000 |
| Financial Assets | - | - | - | $1,729,000 |
| Other Receivables | - | - | - | $12,000 |
| Debt | ||||
| Total Debt | $525,000 | $574,000 | $9,081,000 | $8,830,000 |
| Current Debt And Capital Lease Obligation | $525,000 | $574,000 | $4,744,000 | $1,178,000 |
| Current Debt | $525,000 | $574,000 | $4,744,000 | $1,178,000 |
| Other Current Borrowings | $525,000 | $574,000 | $4,744,000 | $1,178,000 |
| Net Debt | - | - | $8,905,000 | $8,783,000 |
| Long Term Debt And Capital Lease Obligation | - | - | $4,337,000 | $7,652,000 |
| Long Term Debt | - | - | $4,337,000 | $7,652,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $3,742,000 | $6,841,000 | $17,383,000 | $23,800,000 |
| Total Non Current Liabilities Net Minority Interest | $0 | $0 | $4,337,000 | $7,652,000 |
| Current Liabilities | $3,742,000 | $6,841,000 | $13,046,000 | $16,148,000 |
| Other Current Liabilities | $1,000 | $33,000 | $2,307,000 | $10,798,000 |
| Payables And Accrued Expenses | $3,216,000 | $6,234,000 | $5,895,000 | $4,172,000 |
| Payables | $948,000 | $3,046,000 | $4,372,000 | $1,927,000 |
| Accounts Payable | $948,000 | $3,046,000 | $4,372,000 | $1,927,000 |
| Current Deferred Liabilities | - | $0 | $100,000 | - |
| Interest Payable | - | - | $19,000 | $112,000 |
| Derivative Product Liabilities | - | - | - | $0 |
| Current Notes Payable | - | - | - | $1,178,000 |
| Equity | ||||
| Common Stock Equity | $10,416,000 | $-2,183,000 | $-13,870,000 | $-20,762,000 |
| Total Equity Gross Minority Interest | $10,416,000 | $-2,183,000 | $-13,870,000 | $-20,762,000 |
| Stockholders Equity | $10,416,000 | $-2,183,000 | $-13,870,000 | $-20,762,000 |
| Retained Earnings | $-151,714,000 | $-139,564,000 | $-114,734,000 | $-88,502,000 |
| Preferred Securities Outside Stock Equity | - | - | - | - |
| Other | ||||
| Ordinary Shares Number | $3,844,613 | $597,724 | $190,461 | $50,798 |
| Share Issued | $3,844,613 | $597,724 | $190,461 | $50,798 |
| Tangible Book Value | $10,416,000 | $-2,183,000 | $-13,870,000 | $-20,762,000 |
| Invested Capital | $10,941,000 | $-1,609,000 | $-4,789,000 | $-11,932,000 |
| Working Capital | $9,838,000 | $-3,075,000 | $-10,738,000 | $-14,629,000 |
| Total Capitalization | $10,416,000 | $-2,183,000 | $-9,533,000 | $-13,110,000 |
| Additional Paid In Capital | $162,126,000 | $137,379,000 | $100,863,000 | $67,739,000 |
| Capital Stock | $4,000 | $2,000 | $1,000 | $1,000 |
| Common Stock | $4,000 | $2,000 | $1,000 | $1,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Current Accrued Expenses | $2,268,000 | $3,188,000 | $1,523,000 | $2,245,000 |
| Current Deferred Revenue | - | $0 | $100,000 | - |
Fetched: 2026-06-24
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-13,599,000 | $-16,007,000 | $-10,285,000 | $-7,794,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-13,599,000 | $-16,007,000 | $-10,285,000 | $-7,794,000 |
| Cash Flow From Continuing Operating Activities | $-13,599,000 | $-16,007,000 | $-10,285,000 | $-7,794,000 |
| Operating Gains Losses | $-32,000 | $697,000 | $5,712,000 | $-50,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $16,126,000 | $17,441,000 | $6,612,000 | $10,001,000 |
| Financing Cash Flow | $23,760,000 | $17,650,000 | $10,414,000 | $7,331,000 |
| Cash Flow From Continuing Financing Activities | $23,760,000 | $17,650,000 | $10,414,000 | $7,331,000 |
| Net Common Stock Issuance | $16,126,000 | $17,441,000 | $6,612,000 | $10,001,000 |
| Common Stock Issuance | $16,126,000 | $17,441,000 | $6,612,000 | $10,001,000 |
| Net Other Financing Charges | - | - | $-500,000 | $-1,211,000 |
| Net Preferred Stock Issuance | - | - | - | - |
| Preferred Stock Issuance | - | - | - | - |
| Other | ||||
| Repayment Of Debt | $-834,000 | $-6,102,000 | $-5,270,000 | $-78,000 |
| Issuance Of Debt | $767,000 | $1,692,000 | $8,800,000 | $3,559,000 |
| Interest Paid Supplemental Data | $0 | $553,000 | $1,126,000 | $6,000 |
| Income Tax Paid Supplemental Data | $3,000 | $3,000 | $0 | $1,000 |
| End Cash Position | $11,980,000 | $1,819,000 | $176,000 | $47,000 |
| Beginning Cash Position | $1,819,000 | $176,000 | $47,000 | $510,000 |
| Changes In Cash | $10,161,000 | $1,643,000 | $129,000 | $-463,000 |
| Proceeds From Stock Option Exercised | $7,701,000 | $4,619,000 | $772,000 | $-4,940,000 |
| Net Issuance Payments Of Debt | $-67,000 | $-4,410,000 | $3,530,000 | $3,481,000 |
| Net Long Term Debt Issuance | $-67,000 | $-4,410,000 | $3,530,000 | $3,481,000 |
| Long Term Debt Payments | $-834,000 | $-6,102,000 | $-5,270,000 | $-78,000 |
| Long Term Debt Issuance | $767,000 | $1,692,000 | $8,800,000 | $3,559,000 |
| Change In Working Capital | $-2,357,000 | $992,000 | $2,877,000 | $2,552,000 |
| Change In Other Current Liabilities | $0 | $-100,000 | $0 | - |
| Change In Other Current Assets | $314,000 | $313,000 | $0 | - |
| Change In Payables And Accrued Expense | $-3,018,000 | $594,000 | $2,962,000 | $3,621,000 |
| Change In Accrued Expense | $-920,000 | $1,875,000 | $517,000 | $2,073,000 |
| Change In Payable | $-2,098,000 | $-1,281,000 | $2,445,000 | $1,548,000 |
| Change In Account Payable | $-2,098,000 | $-1,281,000 | $2,445,000 | $1,548,000 |
| Change In Prepaid Assets | $538,000 | $297,000 | $-97,000 | $-1,073,000 |
| Change In Inventory | $-66,000 | $0 | - | $0 |
| Change In Receivables | $-125,000 | $-112,000 | $12,000 | $4,000 |
| Changes In Account Receivables | $-125,000 | $-112,000 | $0 | - |
| Other Non Cash Items | $316,000 | $102,000 | $48,000 | $583,000 |
| Stock Based Compensation | $624,000 | $887,000 | $1,930,000 | $1,311,000 |
| Unrealized Gain Loss On Investment Securities | $0 | $6,145,000 | $5,380,000 | $0 |
| Gain Loss On Investment Securities | $-32,000 | $697,000 | $763,000 | $-50,000 |
| Net Income From Continuing Operations | $-12,150,000 | $-24,830,000 | $-26,232,000 | $-12,190,000 |
| Gain Loss On Sale Of PPE | - | - | - | - |
Fetched: 2026-06-24